MedPath
HSA Approval

MAXCARD MODIFIED RELEASE TABLETS 35MG

SIN15092P

MAXCARD MODIFIED RELEASE TABLETS 35MG

MAXCARD MODIFIED RELEASE TABLETS 35MG

September 28, 2016

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED, EXTENDED RELEASE

ORAL

Medical Information

C01EB15

trimetazidine

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

USV Private Limited

Active Ingredients

Trimetazidine Dihydrochloride

35mg

Trimetazidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MAXCARD MODIFIED RELEASE TABLETS 35MG - HSA Approval | MedPath